Q3 2024 Holdings
Filed 2024-11-14 | 68 holdings | $6.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $159.3M | 2,712,096 | 2.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $169.8M | 5,919,435 | 2.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $186.2M | 6,654,033 | 2.7% |
| Masimo Corp(MASI) | COM | 574795100 | $195.0M | 1,462,400 | 2.8% |
| Geron Corp(GERN) | COM | 374163103 | $200.3M | 44,111,916 | 2.9% |
| Merus N V | COM | N5749R100 | $208.3M | 4,169,393 | 3.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $210.8M | 13,707,506 | 3.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $238.9M | 3,272,008 | 3.5% |
| Bruker Corp(BRKR) | COM | 116794108 | $240.4M | 3,481,119 | 3.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $244.2M | 5,426,112 | 3.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $244.9M | 6,818,641 | 3.5% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $274.3M | 7,393,127 | 4.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $326.7M | 17,687,772 | 4.7% |
| Natera Inc(NTRA) | COM | 632307104 | $329.2M | 2,593,323 | 4.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $354.8M | 654,430 | 5.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $373.5M | 8,132,870 | 5.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $376.5M | 4,189,557 | 5.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $423.1M | 1,993,687 | 6.1% |